105 related articles for article (PubMed ID: 26863767)
1. [UROKINASE SYSTEM INVOLVES IN VASCULAR CELLS MIGRATION AND REGULATES THE GROWTH AND BRANCHING OF CAPILLARIES].
Semina EV; Rubina KA; Sysoeva VY; Makarevich PI; Parfyonova YV; Tkachuk VA
Tsitologiia; 2015; 57(10):689-98. PubMed ID: 26863767
[TBL] [Abstract][Full Text] [Related]
2. Role of uPA/uPAR in the modulation of angiogenesis.
Montuori N; Ragno P
Chem Immunol Allergy; 2014; 99():105-22. PubMed ID: 24217605
[TBL] [Abstract][Full Text] [Related]
3. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
4. The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.
Ingram KG; Curtis CD; Silasi-Mansat R; Lupu F; Griffin CT
PLoS Genet; 2013; 9(12):e1004031. PubMed ID: 24348274
[TBL] [Abstract][Full Text] [Related]
5. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
7. Urokinase receptor regulates nerve regeneration through its interaction with α5β1-integrin.
Klimovich PS; Semina EV; Karagyaur MN; Rysenkova KD; Sysoeva VY; Mironov NA; Sagaradze GD; Az'muko AA; Popov VS; Rubina KA; Tkachuk VA
Biomed Pharmacother; 2020 May; 125():110008. PubMed ID: 32187956
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. VEGF-initiated angiogenesis and the uPA/uPAR system.
Breuss JM; Uhrin P
Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133
[TBL] [Abstract][Full Text] [Related]
10. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
12. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
[TBL] [Abstract][Full Text] [Related]
13. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
Tang L; Han X
Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
[TBL] [Abstract][Full Text] [Related]
14. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
[TBL] [Abstract][Full Text] [Related]
15. Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes.
Botta A; Delteil F; Mettouchi A; Vieira A; Estrach S; Négroni L; Stefani C; Lemichez E; Meneguzzi G; Gagnoux-Palacios L
J Cell Sci; 2012 Sep; 125(Pt 18):4241-52. PubMed ID: 22641690
[TBL] [Abstract][Full Text] [Related]
16. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
[TBL] [Abstract][Full Text] [Related]
17. N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.
Whyte C; Thies F; Peyrol L; Balcerzak D
J Nutr Biochem; 2012 Nov; 23(11):1378-83. PubMed ID: 22221673
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.
Fleetwood AJ; Achuthan A; Schultz H; Nansen A; Almholt K; Usher P; Hamilton JA
J Immunol; 2014 Apr; 192(8):3540-7. PubMed ID: 24616477
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of Urokinase-Type Plasminogen Activator Receptor Is Associated with the Development of Perivascular Fibrosis in Mouse Heart.
Dergilev KV; Beloglazova IB; Tsokolaeva ZI; Vasilets YD; Parfenova EV
Bull Exp Biol Med; 2022 May; 173(1):5-9. PubMed ID: 35622258
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
